Omeprazole Sodium is the sodium salt form of a benzimidazole with selective and irreversible proton pump inhibitor activity. In the acidic compartment of parietal cells, omeprazole is protonated and converted into the active achiral sulfenamide; the active sulfenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Losec Sodium, Andra and Esomeprazole sodium (Nexium I.V.). Its PubChem CID is 10959536.
Omeprazole sodium
| CAS No | 95510-70-6 |
|---|---|
| Molecular Formula | C17H18N3NaO3S |
| Molecular Weight | 367.4 g/mol |
| Synonyms | sodium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Omeprazole Sodium is the sodium salt form of a benzimidazole with selective and irreversible proton pump inhibitor activity.
The listed CAS number is 95510-70-6.
The listed molecular formula is C17H18N3NaO3S.
The listed molecular weight is 367.4 g/mol.
sodium;5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide.
The source lists Losec Sodium, Andra and Esomeprazole sodium (Nexium I.V.).